Table 2.
IHC assay of clinical association of FAM129A level change with ccRCC
| Characteristics | No. of specimen (30 in total) | FAM129A immunoreactivity degree | P value | |||
|---|---|---|---|---|---|---|
| − | + | ++ | +++ | |||
| Age, years | ||||||
| ≤60 | 18 | 0 | 1 | 6 | 11 | 0.8 |
| >60 | 12 | 0 | 1 | 4 | 7 | |
| Gender | ||||||
| Male | 22 | 0 | 1 | 8 | 13 | 1 |
| Female | 8 | 0 | 1 | 2 | 5 | |
| Tumor position | ||||||
| Left kidney | 22 | 0 | 1 | 8 | 13 | 1 |
| Right kidney | 8 | 0 | 1 | 2 | 5 | |
| Fuhrman grade | ||||||
| I-II | 14 | 0 | 0 | 4 | 10 | 0.17 |
| III-IV | 16 | 0 | 2 | 6 | 8 | |
| TNM stage | ||||||
| T1 | 15 | 0 | 1 | 8 | 6 | 0.01 |
| T2 | 8 | 0 | 1 | 1 | 6 | |
| T3-4 | 7 | 0 | 0 | 1 | 6 | |
IHC immunohistochemistry, ccRCC clear cell renal cell carcinoma